Alzheimer's Gene Therapy Could Help Protect the Brain From Damage and Preserve Cognitive Function

Alzheimer's gene therapy could help protect the brain from damage and preserve cognitive function

Researchers at University of California San Diego School of Medicine have developed a gene therapy for Alzheimer's disease that could help protect the brain from damage and preserve cognitive function.

Rosemary has been linked to better memory, lower anxiety and even protection from Alzheimer’s

Anna Nahabed/ShutterstockRosemary (Rosmarinus officinalis), the aromatic herb native to the Mediterranean, has long been treasured in kitchens around the world. But beyond its culinary charm, rosemary is also gaining recognition for its impressive health benefits, especially when it comes to brain health, inflammation and immune function. Research suggests rosemary may even hold promise in the fight against Alzheimer’s disease, the leading cause…

Coping with Alzheimer's Disease

One of the most, if not the most, devastating medical problems of our time is Alzheimer’s disease. This disease slowly but inevitably invades its victims and inches its way toward

Boosting brain's self-cleansing system helps clear Alzheimer's toxins in mice

Columbia scientists have found that boosting the performance of a self-cleansing system in the brain helps flush amyloid and tau toxins from the brains of mice and improves the animals' cognition.

Why you don’t have to worry (too much) about Alzheimer’s if you have herpes

Life is the result of a delicate balance, and what saves us at one moment can kill us the next. A recent study shows that the tau protein protects against the neuronal damage caused by herpes (HSV-1) infection, and a similar protective role has also been identified for beta-amyloid. Seguir leyendo

Designing the next-generation clinical care pathway for Alzheimer’s disease

The reconceptualization of Alzheimer’s disease (AD) as a clinical and biological construct has facilitated the development of biomarker-guided, pathway-based targeted therapies, many of which have reached late-stage development with the near-term potential to enter global clinical practice. These medical advances mark an unprecedented paradigm shift and requires an optimized global framework for clinical care pathways for AD. In this Perspective…